OssDsign AB (publ) (STO:OSSD)
Sweden · Delayed Price · Currency is SEK 4.140
+0.025 (0.61%)
Jun 12, 2026, 5:29 PM CET
OssDsign AB Company Description
OssDsign AB (publ) designs, manufactures, and sells implants and material technology for bone regeneration in the United States.
The company offers OssDsign Catalyst, a nanosynthetic bone graft engages in dual bone formation pathways through fusion mass.
OssDsign AB (publ) was founded in 2011 and is headquartered in Uppsala, Sweden.
OssDsign AB (publ)
| Country | Sweden |
| Founded | 2011 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 35 |
| CEO | Mark Waugh |
Contact Details
Address: Ulls väg 29C Uppsala, 756 51 Sweden | |
| Phone | 46 1 84 30 81 10 |
| Website | ossdsign.com |
Stock Details
| Ticker Symbol | OSSD |
| Exchange | Nasdaq Stockholm |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| ISIN Number | SE0012570448 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Mark Waugh B.S., M.B.A. | Chief Executive Officer |
| Anders Svensson | Chief Financial Officer |
| Dr. Tom Buckland Ph.D. | Chief Technical Officer |
| Stephen Anderson | Vice President of Marketing |
| Melanie Marshall | Vice President of Clinical and Medical Affairs |
| Eric Patermo | Vice President of Sales US |